WPA
VIR icon

Wealth Preservation Advisors’s Vir Biotechnology VIR Stock Holding History

Wealth Preservation Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,968
Closed -$17.6K – 916
2026
Q1 		$17.6K Buy
1,968
+31
+2% +$247 0.01% 331
2025
Q4 		$11.7K Hold
1,937
– – 0.01% 291
2025
Q3 		$11.1K Hold
1,937
– – 0.01% 284
2025
Q2 		$9.76K Hold
1,937
– – 0.01% 293
2025
Q1 		$12.6K Buy
+1,937
New +$17.2K 0.01% 298

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wealth Preservation Advisors's VIR Position: Q2 2026 in Review

Wealth Preservation Advisors sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 1,968 shares — an estimated $17.6K sold.

Wealth Preservation Advisors first reported a position in VIR in Q1 2025 and held it in 5 quarters. The position peaked at $17.6K in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Wealth Preservation Advisors reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Wealth Preservation Advisors sold 1,968 Vir Biotechnology shares in Q2 2026, an estimated $17.6K.
  • Wealth Preservation Advisors first reported a position in Vir Biotechnology in Q1 2025 and held it in 5 quarters.
  • Wealth Preservation Advisors's Vir Biotechnology position peaked at $17.6K in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Wealth Preservation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.